Studies have found that the upregulation of ANXA2 is associated with liver steatosis, inflammation, and fibrosis; thus, hepatocytes, under the stimulation of excessive lipid accumulation and FFA, accelerate the transition to inflammation and fibrosis through ANXA2 [92]. The gene discussed is ANXA2; the disease is fatty liver disease.